MetaADEDB 2.0 @ LMMD
mirabegron
(PBAPPPCECJKMCM-IBGZPJMESA-N)
Structure
SMILES
O=C(Cc1csc(n1)N)Nc1ccc(cc1)CCNC[C@@H](c1ccccc1)O
Type(s)
Approved
ATC code(s)
G04BD12
Molecular Formula:
C21H24N4O2S
Molecular Weight:
396.506
Log P:
3.8173
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
4
TPSA:
128.51
CAS Number(s):
223673-61-8
Synonym(s)
1.
mirabegron
2.
2-(2-aminothiazol-4-yl)-4'-(2-((2-hydroxy-2-phenylethyl)amino)ethyl)acetanilide
3.
Betanis
4.
Betmiga
5.
YM 178
6.
YM-178
External Link(s)
MeSHC520025
PubChem Compound9865528
ChEBI65349
CHEMBLCHEMBL2095212
DrugBankDB08893
DrugCentral4382
IUPHAR/BPS Guide to PHARMACOLOGY7445
KEGGdr:D09535
Therapeutic Target DatabaseD0X5UN
ZINC1996784
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 1992
Canada Vigilance: 69
Canada Vigilance
US FAERS
2Intentional product misuseFAERS: 1051
Canada Vigilance: 20
Canada Vigilance
US FAERS
3HeadacheFAERS: 423
Canada Vigilance: 13
Canada Vigilance
SIDER
US FAERS
4Drug effect incompleteFAERS: 364US FAERS
5NocturiaFAERS: 286
Canada Vigilance: 8
Canada Vigilance
US FAERS
6Intentional product use issueFAERS: 264
Canada Vigilance: 3
Canada Vigilance
US FAERS
7ConstipationFAERS: 259
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
8DizzinessFAERS: 252
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
9Urinary RetentionFAERS: 241
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
10Urinary IncontinenceFAERS: 226
Canada Vigilance: 2
Canada Vigilance
US FAERS
11Inappropriate schedule of drug administrationFAERS: 222US FAERS
12Urinary tract infectionFAERS: 165SIDER
US FAERS
13NasopharyngitisFAERS: 141
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
14MalaiseFAERS: 135US FAERS
15FatigueFAERS: 114
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
16Wrong technique in product usage processFAERS: 114
Canada Vigilance: 1
Canada Vigilance
US FAERS
17NauseaFAERS: 112
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
18PruritusFAERS: 101
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
19DysuriaFAERS: 100
Canada Vigilance: 4
Canada Vigilance
US FAERS
20Intentional drug misuseFAERS: 98US FAERS
21Drug prescribing errorFAERS: 89US FAERS
22Drug dose omissionFAERS: 87US FAERS
23Peripheral swellingFAERS: 86
Canada Vigilance: 1
Canada Vigilance
US FAERS
24PalpitationsFAERS: 79
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
25Atrial FibrillationFAERS: 75
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
26Feeling abnormalFAERS: 72US FAERS
27PainFAERS: 70
Canada Vigilance: 2
Canada Vigilance
US FAERS
28Abdominal discomfortFAERS: 68
Canada Vigilance: 2
Canada Vigilance
US FAERS
29Back PainFAERS: 60
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
30SomnolenceFAERS: 60
Canada Vigilance: 1
Canada Vigilance
US FAERS
31UrticariaFAERS: 60
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
32OverdoseFAERS: 57
Canada Vigilance: 4
Canada Vigilance
US FAERS
33ArthralgiaFAERS: 56
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
34HypersensitivityFAERS: 55
Canada Vigilance: 2
Canada Vigilance
US FAERS
35AstheniaFAERS: 53
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
36Cerebrovascular accidentFAERS: 48
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
37AlopeciaFAERS: 47
Canada Vigilance: 1
Canada Vigilance
US FAERS
38Abdominal PainFAERS: 45
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
39CystitisFAERS: 45SIDER
US FAERS
40Blood glucose increasedFAERS: 44US FAERS
41Hypertensive crisisFAERS: 43
Canada Vigilance: 1
Canada Vigilance
US FAERS
42Joint swellingFAERS: 43SIDER
US FAERS
43VomitingFAERS: 42
Canada Vigilance: 1
Canada Vigilance
US FAERS
44TachycardiaFAERS: 39SIDER
US FAERS
45Drug ineffective for unapproved indicationFAERS: 38
Canada Vigilance: 3
Canada Vigilance
US FAERS
46Lip swellingFAERS: 38US FAERS
47Oropharyngeal painFAERS: 38US FAERS
48Product use issueFAERS: 38US FAERS
49Circumstance or information capable of leading to medication errorFAERS: 35US FAERS
50Wrong technique in drug usage processFAERS: 35US FAERS
51DementiaFAERS: 33
Canada Vigilance: 1
Canada Vigilance
US FAERS
52Memory impairmentFAERS: 31
Canada Vigilance: 1
Canada Vigilance
US FAERS
53Product packaging quantity issueFAERS: 31US FAERS
54Urine flow decreasedFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
55ChromaturiaFAERS: 29US FAERS
56DyspepsiaFAERS: 29SIDER
US FAERS
57IncontinenceFAERS: 29
Canada Vigilance: 1
Canada Vigilance
US FAERS
58AnxietyFAERS: 27
Canada Vigilance: 2
Canada Vigilance
US FAERS
59TremorFAERS: 27US FAERS
60Blood urine presentFAERS: 26US FAERS
61Chest PainFAERS: 26US FAERS
62EpistaxisFAERS: 26US FAERS
63Myocardial InfarctionFAERS: 26US FAERS
64SyncopeFAERS: 26
Canada Vigilance: 3
Canada Vigilance
US FAERS
65Visual ImpairmentFAERS: 26
Canada Vigilance: 1
Canada Vigilance
US FAERS
66Adverse eventFAERS: 25
Canada Vigilance: 2
Canada Vigilance
US FAERS
67Weight decreasedFAERS: 25US FAERS
68ErythemaFAERS: 24US FAERS
69InfluenzaFAERS: 24SIDER
US FAERS
70Burning sensationFAERS: 23US FAERS
71Drug dispensing errorFAERS: 23US FAERS
72TinnitusFAERS: 23US FAERS
73AmnesiaFAERS: 22US FAERS
74HypotensionFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
75FlatulenceFAERS: 21US FAERS
76MyalgiaFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
77NervousnessFAERS: 20US FAERS
78Product storage errorFAERS: 19US FAERS
79Urine output increasedFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
80Incorrect dose administeredFAERS: 18US FAERS
81AngioedemaFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
82PneumoniaFAERS: 17US FAERS
83SneezingFAERS: 17US FAERS
84SwellingFAERS: 17US FAERS
85Accidental overdoseFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
86Bladder painFAERS: 16SIDER
US FAERS
87Bladder spasmFAERS: 16US FAERS
88Chest discomfortFAERS: 15US FAERS
89Eye painFAERS: 14US FAERS
90Night sweatsFAERS: 14US FAERS
91SinusitisFAERS: 14SIDER
US FAERS
92ThirstFAERS: 14US FAERS
93Blood pressure fluctuationFAERS: 13
Canada Vigilance: 2
Canada Vigilance
US FAERS
94DehydrationFAERS: 13US FAERS
95DiscomfortFAERS: 13US FAERS
96DysphoniaFAERS: 13US FAERS
97Head discomfortFAERS: 13US FAERS
98Incorrect product storageFAERS: 13US FAERS
99Multiple SclerosisFAERS: 13US FAERS
100ArthritisFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
101DisorientationFAERS: 12US FAERS
102DysgeusiaFAERS: 12US FAERS
103Expired product administeredFAERS: 12US FAERS
104LethargyFAERS: 12US FAERS
105No adverse eventFAERS: 12US FAERS
106Therapeutic response unexpectedFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
107ThrombosisFAERS: 12US FAERS
108Vulvovaginal pruritusFAERS: 12SIDER
US FAERS
109Blood sodium decreasedFAERS: 11US FAERS
110General physical health deteriorationFAERS: 11US FAERS
111InfectionFAERS: 11SIDER
US FAERS
112LaryngitisFAERS: 11US FAERS
113Urge IncontinenceFAERS: 11US FAERS
114VertigoFAERS: 11US FAERS
115BlindnessFAERS: 10US FAERS
116BronchitisFAERS: 10US FAERS
117DeliriumFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
118Diabetes MellitusFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
119Dry skinFAERS: 10US FAERS
120Feeling jitteryFAERS: 10US FAERS
121Neck PainFAERS: 10US FAERS
122Prescribed overdoseFAERS: 10US FAERS
123Product use in unapproved indicationFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
124Throat irritationFAERS: 10US FAERS
125Urinary hesitationFAERS: 10US FAERS
126Angina PectorisFAERS: 9US FAERS
127Cataract operationFAERS: 9US FAERS
128Limb injuryFAERS: 9US FAERS
129Musculoskeletal stiffnessFAERS: 9US FAERS
130Unevaluable eventFAERS: 9US FAERS
131ChillsFAERS: 8US FAERS
132DiplopiaFAERS: 8US FAERS
133Flank PainFAERS: 8US FAERS
134GastritisFAERS: 8SIDER
US FAERS
135Medication residue presentFAERS: 8US FAERS
136Oral painFAERS: 8US FAERS
137Pelvic PainFAERS: 8US FAERS
138Rash erythematousFAERS: 8US FAERS
139RestlessnessFAERS: 8US FAERS
140Rheumatoid ArthritisFAERS: 8US FAERS
141nervous system disorderFAERS: 8US FAERS
142Acute kidney injuryFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
143Back disorderFAERS: 7US FAERS
144Bladder discomfortFAERS: 7US FAERS
145Bladder prolapseFAERS: 7US FAERS
146Blood glucose decreasedFAERS: 7US FAERS
147Bone painFAERS: 7US FAERS
148CataractFAERS: 7US FAERS
149Cerebral InfarctionFAERS: 7US FAERS
150Depressed moodFAERS: 7US FAERS
151EnuresisFAERS: 7US FAERS
152Eye irritationFAERS: 7US FAERS
153FlushingFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
154Gait inabilityFAERS: 7US FAERS
155Mouth swellingFAERS: 7US FAERS
156NephrolithiasisFAERS: 7SIDER
US FAERS
157PetechiaeFAERS: 7US FAERS
158Product size issueFAERS: 7US FAERS
159Residual urine volume increasedFAERS: 7US FAERS
160StomatitisFAERS: 7US FAERS
161Therapy cessationFAERS: 7US FAERS
162AgitationFAERS: 6US FAERS
163AsthmaFAERS: 6US FAERS
164Cold sweatFAERS: 6US FAERS
165FractureFAERS: 6US FAERS
166GlaucomaFAERS: 6SIDER
US FAERS
167IleusFAERS: 6US FAERS
168Limb discomfortFAERS: 6US FAERS
169Macular degenerationFAERS: 6US FAERS
170Middle insomniaFAERS: 6US FAERS
171PresyncopeFAERS: 6US FAERS
172Product label issueFAERS: 6US FAERS
173Product packaging issueFAERS: 6US FAERS
174StressFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
175AcneFAERS: 5US FAERS
176Ankle FractureFAERS: 5US FAERS
177ApathyFAERS: 5US FAERS
178ArthropathyFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
179Blood creatinine increasedFAERS: 5US FAERS
180DisabilityFAERS: 5US FAERS
181Drug administration errorFAERS: 5US FAERS
182Drug effect delayedFAERS: 5US FAERS
183Erectile dysfunctionFAERS: 5US FAERS
184Feeling ColdFAERS: 5US FAERS
185Increased upper airway secretionFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
186Initial insomniaFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
187Musculoskeletal PainFAERS: 5US FAERS
188Nerve injuryFAERS: 5US FAERS
189NeuralgiaFAERS: 5US FAERS
190Poor quality sleepFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
191Product quality issueFAERS: 5US FAERS
192Renal painFAERS: 5US FAERS
193SepsisFAERS: 5US FAERS
194Skin lesionFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
195Upper-airway cough syndromeFAERS: 5US FAERS
196VasculitisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
197Vitreous floatersFAERS: 5US FAERS
198Vulvovaginal burning sensationFAERS: 5US FAERS
199Vulvovaginal painFAERS: 5US FAERS
200AgeusiaFAERS: 4US FAERS
201Alanine Aminotransferase IncreasedFAERS: 4SIDER
US FAERS
202Aspartate Aminotransferase IncreasedFAERS: 4SIDER
US FAERS
203Atrial FlutterFAERS: 4US FAERS
204Bipolar DisorderFAERS: 4US FAERS
205BlepharospasmFAERS: 4US FAERS
206Bowel movement irregularityFAERS: 4US FAERS
207BradycardiaFAERS: 4US FAERS
208CryingFAERS: 4US FAERS
209DeafnessFAERS: 4US FAERS
210Drug effect variableFAERS: 4US FAERS
211DysarthriaFAERS: 4US FAERS
212EczemaFAERS: 4US FAERS
213Emotional disorderFAERS: 4US FAERS
214EpilepsyFAERS: 4US FAERS
215Gastrointestinal PainFAERS: 4SIDER
US FAERS
216GoutFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
217Intercepted medication errorFAERS: 4US FAERS
218Intestinal ObstructionFAERS: 4US FAERS
219Irritable Bowel SyndromeFAERS: 4US FAERS
220Joint stiffnessFAERS: 4US FAERS
221Muscle tightnessFAERS: 4US FAERS
222Product physical issueFAERS: 4US FAERS
223RhinitisFAERS: 4SIDER
US FAERS
224RosaceaFAERS: 4US FAERS
225SciaticaFAERS: 4US FAERS
226Vulvovaginal drynessFAERS: 4US FAERS
227WheezingFAERS: 4US FAERS
228Accidental exposure to product by childFAERS: 3US FAERS
229AnosmiaFAERS: 3US FAERS
230Anti-neutrophil cytoplasmic antibody positive vasculitisFAERS: 3US FAERS
231Apparent deathFAERS: 3US FAERS
232Benign Prostatic HyperplasiaFAERS: 3US FAERS
233Blood glucose fluctuationFAERS: 3US FAERS
234Breast tendernessFAERS: 3US FAERS
235ChokingFAERS: 3US FAERS
236ConjunctivitisFAERS: 3US FAERS
237Drug effective for unapproved indicationFAERS: 3US FAERS
238Emotional distressFAERS: 3US FAERS
239Food AllergyFAERS: 3US FAERS
240Gastrointestinal motility disorderFAERS: 3US FAERS
241Gluten sensitivityFAERS: 3US FAERS
242InflammationFAERS: 3US FAERS
243Joint injuryFAERS: 3US FAERS
244Lower respiratory tract infectionFAERS: 3US FAERS
245LymphadenopathyFAERS: 3US FAERS
246Medication ErrorFAERS: 3US FAERS
247Mental status changesFAERS: 3US FAERS
248Multiple sclerosis relapseFAERS: 3US FAERS
249Musculoskeletal discomfortFAERS: 3SIDER
US FAERS
250Myasthenia GravisFAERS: 3US FAERS
251Nasal discomfortFAERS: 3US FAERS
252Ocular discomfortFAERS: 3US FAERS
253Oral candidiasisFAERS: 3US FAERS
254PharyngitisFAERS: 3US FAERS
255Poor quality drug administeredFAERS: 3US FAERS
256Productive CoughFAERS: 3US FAERS
257PsoriasisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
258Quality of life decreasedFAERS: 3US FAERS
259Sinus headacheFAERS: 3US FAERS
260ToothacheFAERS: 3US FAERS
261Urinary incontinence surgeryFAERS: 3US FAERS
262Vulvovaginal discomfortFAERS: 3US FAERS
263Vulvovaginal mycotic infectionFAERS: 3US FAERS
264Wrong drug administeredFAERS: 3US FAERS
265AbasiaFAERS: 2US FAERS
266Abdominal rigidityFAERS: 2US FAERS
267Accidental exposure to productFAERS: 2US FAERS
268Activities of daily living impairedFAERS: 2US FAERS
269AneurysmFAERS: 2US FAERS
270Animal biteFAERS: 2US FAERS
271AnuriaFAERS: 2US FAERS
272AphagiaFAERS: 2US FAERS
273AphasiaFAERS: 2US FAERS
274Basal ganglia strokeFAERS: 2US FAERS
275Biliary cirrhosisFAERS: 2US FAERS
276Bladder cancer recurrentFAERS: 2US FAERS
277Bladder dysfunctionFAERS: 2US FAERS
278Bladder neck suspensionFAERS: 2US FAERS
279BlepharitisFAERS: 2US FAERS
280Blood alkaline phosphatase increasedFAERS: 2US FAERS
281Blood blisterFAERS: 2US FAERS
282Blood cholesterol increasedFAERS: 2US FAERS
283Blood creatine phosphokinase increasedFAERS: 2US FAERS
284Blood glucose abnormalFAERS: 2US FAERS
285Blood potassium decreasedFAERS: 2US FAERS
286Blood potassium increasedFAERS: 2US FAERS
287Blood sodium increasedFAERS: 2US FAERS
288Cardiac discomfortFAERS: 2US FAERS
289CheilitisFAERS: 2US FAERS
290Concomitant disease aggravatedFAERS: 2US FAERS
291Coronary Artery DiseaseFAERS: 2US FAERS
292Deep Vein ThrombosisFAERS: 2US FAERS
293Dental cariesFAERS: 2US FAERS
294Depressed Level of ConsciousnessFAERS: 2US FAERS
295DermatitisFAERS: 2SIDER
US FAERS
296Device leakageFAERS: 2US FAERS
297DroolingFAERS: 2US FAERS
298Drug screen false positiveFAERS: 2US FAERS
299Electrolyte imbalanceFAERS: 2US FAERS
300EndocarditisFAERS: 2US FAERS
301Escherichia urinary tract infectionFAERS: 2US FAERS
302Extra dose administeredFAERS: 2US FAERS
303Food PoisoningFAERS: 2US FAERS
304Foreign body sensation in eyesFAERS: 2US FAERS
305Gastric ulcerFAERS: 2US FAERS
306GastroenteritisFAERS: 2US FAERS
307Gastrointestinal infectionFAERS: 2US FAERS
308Genital burning sensationFAERS: 2US FAERS
309Genital rashFAERS: 2US FAERS
310GlioblastomaFAERS: 2US FAERS
311HepatitisFAERS: 2US FAERS
312HerniaFAERS: 2US FAERS
313HydronephrosisFAERS: 2US FAERS
314HypokinesiaFAERS: 2US FAERS
315HysterectomyFAERS: 2US FAERS
316Immune thrombocytopenic purpuraFAERS: 2US FAERS
317Impaired driving abilityFAERS: 2US FAERS
318Impaired quality of lifeFAERS: 2US FAERS
319Impaired work abilityFAERS: 2US FAERS
320Inability to afford medicationFAERS: 2US FAERS
321Intentional dose omissionFAERS: 2US FAERS
322Locked-In SyndromeFAERS: 2US FAERS
323Loss of personal independence in daily activitiesFAERS: 2US FAERS
324Malignant HypertensionFAERS: 2US FAERS
325MetrorrhagiaFAERS: 2US FAERS
326Micturition frequency decreasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
327Migraine with AuraFAERS: 2US FAERS
328Mood swingsFAERS: 2US FAERS
329Musculoskeletal chest painFAERS: 2US FAERS
330Nasal pruritusFAERS: 2US FAERS
331NeutropeniaFAERS: 2US FAERS
332Noninfective gingivitisFAERS: 2US FAERS
333Ocular HypertensionFAERS: 2US FAERS
334OnychoclasisFAERS: 2US FAERS
335Oropharyngeal discomfortFAERS: 2US FAERS
336Pain of skinFAERS: 2US FAERS
337Pancreatic carcinomaFAERS: 2US FAERS
338Pelvic abscessFAERS: 2US FAERS
339Pelvic discomfortFAERS: 2US FAERS
340Peptic UlcerFAERS: 2US FAERS
341PhotophobiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
342PolyneuropathyFAERS: 2US FAERS
343Post procedural complicationFAERS: 2US FAERS
344Product comminglingFAERS: 2US FAERS
345Product dose omissionFAERS: 2US FAERS
346Product prescribing errorFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
347Product use complaintFAERS: 2US FAERS
348Pulmonary EmbolismFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
349PurpuraFAERS: 2SIDER
US FAERS
350PyelonephritisFAERS: 2US FAERS
351Restless Legs SyndromeFAERS: 2US FAERS
352Retinal Vein OcclusionFAERS: 2US FAERS
353Rotator cuff syndromeFAERS: 2US FAERS
354Secretion dischargeFAERS: 2US FAERS
355Sick Sinus SyndromeFAERS: 2US FAERS
356Sinus TachycardiaFAERS: 2US FAERS
357Skin UlcerFAERS: 2US FAERS
358Suspected counterfeit productFAERS: 2US FAERS
359TachyarrhythmiaFAERS: 2US FAERS
360TachyphylaxisFAERS: 2US FAERS
361Therapeutic response delayedFAERS: 2US FAERS
362Therapy non-responderFAERS: 2US FAERS
363Tongue blisteringFAERS: 2US FAERS
364Tooth ExtractionFAERS: 2US FAERS
365TrismusFAERS: 2US FAERS
366Urinary tract obstructionFAERS: 2US FAERS
367Uterine ProlapseFAERS: 2US FAERS
368Vulvovaginal swellingFAERS: 2US FAERS
369White blood cell count decreasedFAERS: 2US FAERS
370treatment failureFAERS: 2US FAERS
371Abdominal tendernessFAERS: 1US FAERS
372Abnormal weight gainFAERS: 1US FAERS
373Acquired corneal dystrophyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
374Acute myocardial infarctionFAERS: 1US FAERS
375AgranulocytosisFAERS: 1US FAERS
376Allergic reaction to excipientFAERS: 1US FAERS
377Alopecia AreataFAERS: 1US FAERS
378Ammonia increasedFAERS: 1US FAERS
379Amphetamines positiveFAERS: 1US FAERS
380Anal UlcerFAERS: 1US FAERS
381Anaphylactic shockFAERS: 1US FAERS
382AngerFAERS: 1US FAERS
383AnhedoniaFAERS: 1US FAERS
384Anorectal discomfortFAERS: 1US FAERS
385AnorgasmiaFAERS: 1US FAERS
386Aortic AneurysmFAERS: 1US FAERS
387AphoniaFAERS: 1US FAERS
388Aphthous StomatitisFAERS: 1US FAERS
389Atypical pneumoniaFAERS: 1US FAERS
390Bacterial VaginosisFAERS: 1US FAERS
391BalanoposthitisFAERS: 1US FAERS
392Basal cell carcinomaFAERS: 1US FAERS
393BedriddenFAERS: 1US FAERS
394Biliary ColicFAERS: 1US FAERS
395BiopsyFAERS: 1US FAERS
396Bipolar I disorderFAERS: 1US FAERS
397Bladder trabeculationFAERS: 1US FAERS
398Blood cholesterolFAERS: 1US FAERS
399Blood creatine increasedFAERS: 1US FAERS
400Blood creatinine abnormalFAERS: 1US FAERS
401Blood phosphorus decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
402Blood pressure immeasurableFAERS: 1US FAERS
403Blood prolactin increasedFAERS: 1US FAERS
404Blood thyroid stimulating hormone increasedFAERS: 1US FAERS
405Blood urea increasedFAERS: 1US FAERS
406BradykinesiaFAERS: 1US FAERS
407Breast cancer stage IIIFAERS: 1US FAERS
408BronchospasmFAERS: 1US FAERS
409Buccal mucosal rougheningFAERS: 1US FAERS
410BursitisFAERS: 1US FAERS
411Capillary FragilityFAERS: 1US FAERS
412Cardiac FlutterFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
413Cardiac HypertrophyFAERS: 1US FAERS
414Cardiac ablationFAERS: 1US FAERS
415Cardiac dysfunctionFAERS: 1US FAERS
416Carotid artery aneurysmFAERS: 1US FAERS
417Carpal Tunnel SyndromeFAERS: 1US FAERS
418Catheter placementFAERS: 1US FAERS
419CellulitisFAERS: 1US FAERS
420Cerebral artery occlusionFAERS: 1US FAERS
421Cerebral disorderFAERS: 1US FAERS
422Cervicobrachial syndromeFAERS: 1US FAERS
423Choking sensationFAERS: 1US FAERS
424CholelithiasisFAERS: 1US FAERS
425Clostridium difficile colitisFAERS: 1US FAERS
426ColitisFAERS: 1US FAERS
427Compression fractureFAERS: 1US FAERS
428Corneal erosionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
429Creatinine renal clearance decreasedFAERS: 1US FAERS
430CystopexyFAERS: 1US FAERS
431Dental discomfortFAERS: 1US FAERS
432Dermatitis HerpetiformisFAERS: 1US FAERS
433Device malfunctionFAERS: 1US FAERS
434Diabetes mellitus inadequate controlFAERS: 1US FAERS
435Diabetes mellitus managementFAERS: 1US FAERS
436Diaphragmatic spasmFAERS: 1US FAERS
437Disease complicationFAERS: 1US FAERS
438DissociationFAERS: 1US FAERS
439DiverticulumFAERS: 1US FAERS
440Drug administered to patient of inappropriate ageFAERS: 1US FAERS
441Drug dispensed to wrong patientFAERS: 1US FAERS
442Drug dispensing issueFAERS: 1US FAERS
443Drug resistanceFAERS: 1US FAERS
444Drug withdrawal syndromeFAERS: 1US FAERS
445DysenteryFAERS: 1US FAERS
446DyspareuniaFAERS: 1US FAERS
447Economic problemFAERS: 1US FAERS
448Electroencephalogram abnormalFAERS: 1US FAERS
449EmbolismFAERS: 1US FAERS
450Emergency CareFAERS: 1US FAERS
451EndometriosisFAERS: 1US FAERS
452EosinophiliaFAERS: 1US FAERS
453EpididymitisFAERS: 1US FAERS
454EructationFAERS: 1US FAERS
455ErysipelasFAERS: 1US FAERS
456Escherichia infectionFAERS: 1US FAERS
457Exposure via fatherFAERS: 1US FAERS
458Eye InfectionFAERS: 1US FAERS
459Eye ulcerFAERS: 1US FAERS
460Eyelid exfoliationFAERS: 1US FAERS
461Eyelid infectionFAERS: 1US FAERS
462Face LiftFAERS: 1US FAERS
463Factor XI DeficiencyFAERS: 1US FAERS
464FibromyalgiaFAERS: 1US FAERS
465Fluid overloadFAERS: 1US FAERS
466FolliculitisFAERS: 1US FAERS
467Foreign body in respiratory tractFAERS: 1US FAERS
468Freezing phenomenonFAERS: 1US FAERS
469FrustrationFAERS: 1US FAERS
470GastrectomyFAERS: 1US FAERS
471Gastric BypassFAERS: 1US FAERS
472Gastric DilatationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
473Gastrointestinal obstructionFAERS: 1US FAERS
474Gastrooesophageal sphincter insufficiencyFAERS: 1US FAERS
475General physical condition abnormalFAERS: 1US FAERS
476Genital dischargeFAERS: 1US FAERS
477Genital infection fungalFAERS: 1US FAERS
478Genital swellingFAERS: 1US FAERS
479Gingival HyperplasiaFAERS: 1US FAERS
480Gingival blisterFAERS: 1US FAERS
481Gingival erythemaFAERS: 1US FAERS
482Glutathione peroxidase increasedFAERS: 1US FAERS
483GranulomaFAERS: 1US FAERS
484HemiplegiaFAERS: 1US FAERS
485Hepatitis AFAERS: 1US FAERS
486HepatomegalyFAERS: 1US FAERS
487Hip surgeryFAERS: 1US FAERS
488HyperacusisFAERS: 1US FAERS
489HypercapniaFAERS: 1US FAERS
490HypersomniaFAERS: 1US FAERS
491Hypertensive emergencyFAERS: 1US FAERS
492Impaired gastric emptyingFAERS: 1US FAERS
493Implant site massFAERS: 1US FAERS
494Inappropriate schedule of product administrationFAERS: 1
Canada Vigilance: 5
Canada Vigilance
US FAERS
495IncoherentFAERS: 1US FAERS
496Incorrect drug administration durationFAERS: 1US FAERS
497Intercepted drug administration errorFAERS: 1US FAERS
498Intercepted product storage errorFAERS: 1US FAERS
499Intervertebral Disc DegenerationFAERS: 1US FAERS
500Joint InstabilityFAERS: 1US FAERS
501KetoacidosisFAERS: 1US FAERS
502LacerationFAERS: 1US FAERS
503Lacrimation decreasedFAERS: 1US FAERS
504Large intestine perforationFAERS: 1US FAERS
505LazinessFAERS: 1US FAERS
506Left Ventricular HypertrophyFAERS: 1US FAERS
507LeukocytosisFAERS: 1US FAERS
508LeukopeniaFAERS: 1US FAERS
509Lichen PlanusFAERS: 1US FAERS
510Ligament ruptureFAERS: 1US FAERS
511Lip exfoliationFAERS: 1US FAERS
512LithotripsyFAERS: 1US FAERS
513Liver AbscessFAERS: 1US FAERS
514Long QT SyndromeFAERS: 1US FAERS
515Low density lipoprotein increasedFAERS: 1US FAERS
516Lumbar herniaFAERS: 1US FAERS
517LymphomaFAERS: 1US FAERS
518Malignant neoplasm progressionFAERS: 1US FAERS
519Mastication disorderFAERS: 1US FAERS
520Mechanical ileusFAERS: 1US FAERS
521Medical device removalFAERS: 1US FAERS
522Meibomian gland dysfunctionFAERS: 1US FAERS
523MenorrhagiaFAERS: 1US FAERS
524Mental impairmentFAERS: 1US FAERS
525Muscle RigidityFAERS: 1US FAERS
526Muscle strainFAERS: 1US FAERS
527MydriasisFAERS: 1US FAERS
528Myocardial necrosis marker increasedFAERS: 1US FAERS
529N-terminal prohormone brain natriuretic peptide increasedFAERS: 1US FAERS
530Nephrotic SyndromeFAERS: 1US FAERS
531Neurostimulator implantationFAERS: 1US FAERS
532Neutrophil count decreasedFAERS: 1US FAERS
533Neutrophilic dermatosisFAERS: 1US FAERS
534Nipple painFAERS: 1US FAERS
535Ocular icterusFAERS: 1US FAERS
536OliguriaFAERS: 1US FAERS
537Omental infarctionFAERS: 1US FAERS
538OnychomycosisFAERS: 1US FAERS
539Oral mucosal erythemaFAERS: 1US FAERS
540Oral pruritusFAERS: 1US FAERS
541OrchitisFAERS: 1US FAERS
542Orthostatic hypertensionFAERS: 1US FAERS
543OsteoporosisFAERS: 1US FAERS
544OverweightFAERS: 1US FAERS
545Packaging design issueFAERS: 1US FAERS
546PallorFAERS: 1US FAERS
547Pancreatic enzymes increasedFAERS: 1US FAERS
548PancreatitisFAERS: 1US FAERS
549PancytopeniaFAERS: 1US FAERS
550Panic DisorderFAERS: 1US FAERS
551ParacentesisFAERS: 1US FAERS
552ParanoiaFAERS: 1US FAERS
553ParaparesisFAERS: 1US FAERS
554ParaplegiaFAERS: 1US FAERS
555ParotitisFAERS: 1US FAERS
556Pelvic massFAERS: 1US FAERS
557Pericardial effusionFAERS: 1US FAERS
558Perineal rashFAERS: 1US FAERS
559Personality ChangeFAERS: 1US FAERS
560Physical disabilityFAERS: 1US FAERS
561PoisoningFAERS: 1US FAERS
562PolydipsiaFAERS: 1US FAERS
563Prescribed underdoseFAERS: 1US FAERS
564Prescription drug used without a prescriptionFAERS: 1US FAERS
565PriapismFAERS: 1US FAERS
566Product administration errorFAERS: 1US FAERS
567Product container seal issueFAERS: 1US FAERS
568Product formulation issueFAERS: 1US FAERS
569Product label on wrong productFAERS: 1US FAERS
570Product lot number issueFAERS: 1US FAERS
571Product name confusionFAERS: 1US FAERS
572Product solubility abnormalFAERS: 1US FAERS
573Product substitution issueFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
574Prostate examination abnormalFAERS: 1US FAERS
575PseudoanginaFAERS: 1US FAERS
576Pulmonary FibrosisFAERS: 1US FAERS
577Pulmonary congestionFAERS: 1US FAERS
578Pulmonary thrombosisFAERS: 1US FAERS
579PurulenceFAERS: 1US FAERS
580Reaction to drug excipientsFAERS: 1US FAERS
581Recall phenomenonFAERS: 1US FAERS
582Reduced bladder capacityFAERS: 1US FAERS
583Reflux gastritisFAERS: 1US FAERS
584Renal ColicFAERS: 1US FAERS
585Renal cystFAERS: 1US FAERS
586Respiratory FailureFAERS: 1US FAERS
587Respiratory arrestFAERS: 1US FAERS
588Respiratory distressFAERS: 1US FAERS
589Respiratory tract congestionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
590Retinal Artery OcclusionFAERS: 1US FAERS
591Retinal DetachmentFAERS: 1US FAERS
592RhabdomyolysisFAERS: 1US FAERS
593RhinalgiaFAERS: 1US FAERS
594ScabFAERS: 1US FAERS
595Sensorimotor disorderFAERS: 1US FAERS
596Septic ShockFAERS: 1US FAERS
597Sexual DysfunctionFAERS: 1US FAERS
598Sinus bradycardiaFAERS: 1US FAERS
599Sinus painFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
600Skin WrinklingFAERS: 1US FAERS
601Skin cosmetic procedureFAERS: 1US FAERS
602Skin hypertrophyFAERS: 1US FAERS
603Skin irritationFAERS: 1US FAERS
604Skin reactionFAERS: 1US FAERS
605Skin toxicityFAERS: 1US FAERS
606SluggishnessFAERS: 1US FAERS
607Spinal column stenosisFAERS: 1US FAERS
608Spontaneous penile erectionFAERS: 1US FAERS
609Stevens-Johnson SyndromeFAERS: 125811541CTD
SIDER
US FAERS
610Sudden deathFAERS: 1US FAERS
611Suicide attemptFAERS: 1US FAERS
612SunburnFAERS: 1US FAERS
613Suprapubic painFAERS: 1US FAERS
614Supraventricular tachycardiaFAERS: 1US FAERS
615TachyphreniaFAERS: 1US FAERS
616Temporal ArteritisFAERS: 1US FAERS
617TensionFAERS: 1US FAERS
618Therapeutic product effect decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
619Therapeutic product effect incompleteFAERS: 1
Canada Vigilance: 10
Canada Vigilance
US FAERS
620Therapy changeFAERS: 1US FAERS
621ThrombocytopeniaFAERS: 1US FAERS
622Thrombocytopenic purpuraFAERS: 1US FAERS
623ThrombocytosisFAERS: 1US FAERS
624Tongue pigmentationFAERS: 1US FAERS
625Tooth LossFAERS: 1US FAERS
626Troponin increasedFAERS: 1US FAERS
627Upper respiratory tract congestionFAERS: 1US FAERS
628UreteroceleFAERS: 1US FAERS
629Urinary strainingFAERS: 1US FAERS
630Urinary tract infection staphylococcalFAERS: 1US FAERS
631Urine osmolarity increasedFAERS: 1US FAERS
632Uterine CancerFAERS: 1US FAERS
633UveitisFAERS: 1US FAERS
634Vaginal DischargeFAERS: 1US FAERS
635Vascular painFAERS: 1US FAERS
636Viral upper respiratory tract infectionFAERS: 1US FAERS
637Vitamin D DeficiencyFAERS: 1US FAERS
638Vocal Cord DysfunctionFAERS: 1US FAERS
639Vocal Cord ParalysisFAERS: 1US FAERS
640Vulvovaginal rashFAERS: 1US FAERS
641Walking aid userFAERS: 1US FAERS
642Wedge resection toenailFAERS: 1US FAERS
643Wrong patient received medicationFAERS: 1US FAERS
644Wrong product administeredFAERS: 1US FAERS
645Wrong strengthFAERS: 1US FAERS
646cancer surgeryFAERS: 1US FAERS
647pseudomembranous colitisFAERS: 1US FAERS
648Application site rashCanada Vigilance: 1Canada Vigilance
649Blood lactate dehydrogenase increasedSIDER
650Erythema MultiformeSIDER
651Gamma-Glutamyltransferase IncreasedSIDER
652InfestationSIDER
653Lactic dehydrogenase activity increasedSIDER
654Leukocytoclastic vasculitisSIDER
655Potentiating drug interactionCanada Vigilance: 1Canada Vigilance
656Vascular purpuraSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.